Abstract
Herbal remedies have been widely used in many countries for centuries, and the products enjoyed a surge in popularity in the USA during the late '90s. During the past 20 years, an estimated 2 billion daily doses (120 mg) of Ginkgo biloba (GB) have been sold. French and German agencies consider it to be effective for the treatment of several diseases, and the immense amount of clinical studies concerning GB makes it worth revising the existing literature about this notable plant. Also, the National Institutes of Health (NIH) supports research on alternative therapies that include examining the effects of GB. With the rapid expansion of herbal medicine use in the United States, it is clear that our understanding of herb-herb, drug-herb and food-herb interactions should increase.
Authors who publish with this journal agree to the following terms:
a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).